ZACK, Donald,JASKULA-RANGA, Vinod,WELSBIE, Derek S.
申请号：
CL2019000025
公开号：
CL2019000025A1
申请日:
2019.01.04
申请国别(地区):
CL
年份:
2019
代理人:
摘要：
1. All materials contained in this document are:The composition described and M AMP； EACUTE； all of these include improvements to the RISPR system (for example,CRISPR-PROTE AMP； IACUTE； NA Associate (CAS) 9 (CRISPR-CAS9)；(CRISPR sin CAS9). These components may include changes to regional and provincial, Oacute and H1 advocates.ADEM AMP； AACUTE； S changed to UTR 5 AMP； ACUTE；Different ORT AMP sequences； OACUTE； H1 salesman Logas,A new series of compact bilateral salesmen of the Convention for the Prevention of Ship Pollution II and the Convention for the Prevention of Ship Pollution III,ADICI AMP； OACUTE； Kozak consensus sequence N,Termination and Ampere Sequence； OACUTE； NAditi Amp； Oacute； N de la Expui Amp； Oacute； N Condition of the Bilateral Promotion POLII/POL III,Comments more than a month agoOr a combination of both Other aspects of the invention: Oacute； N involves from CAS9 to TRAV AMP； EACUTE； S involves the merger of CI AMP； OACUTE； N involves the post-treatment of cell cycle.Target design and amp； Ntilde； by Ingenier Amp； IACUTE； Gene and amp； EACUTE； TICA； so that the core can be added without isolating DNA.Self-Translating Self-Reviewing Website； Oacute； n.And modify N-terminal to modulate average lifetime； LT； / P GT；<；p>；LA MATERIA AQUÍ； DESCRITA PROPORCIONA COMPOSICIONES Y MÉ；TODOS QUE COMPRENDEN MEJORAS DE UN SISTEMA CRISPR (POR EJEMPLO, CRISPR-PROTEÍ；NA ASOCIADA (CAS) 9 (SISTEMA CRISPR-CAS9, SISTEMAS CRISPR SIN CAS9). TALES COMPOSICIONES PUEDEN COMPRENDER MODIFICACIONES EN LA REGIÓ；N PROMOTORA H1, ADEMÁ；S DE MODIFICACIONES EN UTR 5´；, DIFERENTES SECUENCIAS ORTÓ；LOGAS DEL PROMOTOR H1, NUEVAS SECUENCIAS DEL PROMOTOR BIDIRECCIONAL COMPACTO CON ACTIVIDAD TANTO POL II COMO POL III, ADICIÓ；N DE SECUENCIAS DE CONSENSO DE KOZAK, SECUENCIAS DE TERMINACIÓ；N, ADICIÓ；N DE LA EXPRESIÓ；N CONDICIONAL DEL PROMOTOR BIDIRECCIONAL POL II/POL III, ADICIÓ；N DE UNA SECUENCIA MOLDE DONANT
